• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Resources
    • Resources Overview
    • Elevated Insights
    • Presentations & Publications
    • Whitepapers
  • Media
    • Media Overview
    • Press Releases
    • Featured News
  • Facilities
  • Careers
  • Contact
  • Search
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact
  • Manufacturing & Discovery Services

    Manufacturing & Discovery Services Overview

    Capabilities & Services
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
    • Investors

Presentations & Publications

// May 17, 2025 | Presentation

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Advancing Lentiviral Vector Manufacturing: A Platform for Commercial Cell Therapy Success

View Presentation

// May 17, 2025 | Presentation

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Broad Biodistribution and Expression of Allele Selective LETI-101 in Critical Brain Regions for Treatment of Huntington’s Disease Following Intrastriatal Delivery in NHP

View Presentation

// May 15, 2025 | Poster

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Deep CRISPR Nuclease Portfolio and Multiple Editing Modalities Accelerates Identification of Viable Clinical Candidates

View Poster

// May 15, 2025 | Poster

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Peripheral Blood Mononuclear Cell (PBMC) Isolation Using Cell Fractionation Filters

View Poster

// May 14, 2025 | Poster

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Signature of Base Editor RNA Edits in the Transcriptome and Reduction of Exogenous RNA Editing

View Poster

// May 13, 2025 | Poster

American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Electroporation and Lipid Nanoparticles as Delivery Methods for Targeted CRISPR/Cas9 Gene Editing in Primary Human T-Cells

View Poster

// May 07, 2025 | Poster

International Society for Cell & Gene Therapy New Orleans, LA

Evaluating Buoyancy Activated Cell Sorting (BACS) for T cell Isolation in CAR-T Manufacturing

View Poster

// Apr 07, 2025 | Presentation

CRISPR Medicines 2025 Conference Copenhagen, DK

Harnessing a diverse collection of CRISPR-associated RNA-guided nucleases and a proprietary nonviral delivery platform for precise gene editing

View Presentation

// Feb 25, 2025 | Presentation

20th Annual Huntington's Disease Therapeutics Conference Palm Springs, CA

AAV5-delivered Life Edit® CRISPR system results in broad CNS biodistribution and allele selective editing and reduction of mHTT protein in critical HD brain regions

View Presentation

// Feb 02, 2025 | Presentation

3rd Viral Vector Process Development & Manufacturing Summit Boston, MA

Novel Approach to Treating Rare Disease Using an AAV Vector to Deliver Gene Editing Tools to the Brain

View Presentation

// Jan 31, 2025 | Presentation

5th Annual Summit of Biologics Conference and Workshop on Biopharmaceutical Product Development Goa, India

Potency Development for Cell & Gene Therapy Products

View Presentation

// Jan 21, 2025 | Presentation

Phacilitate Advanced Therapies Week Dallas, Texas

Driving Innovation and Scalability In Advanced Therapies

View Presentation

  • Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2026 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Discovery Services
  • Technologies
  • Advanced Therapies
  • Partner With Us
  • About
  • Presentations & Publications
  • Elevated Insights
  • Careers
  • Facilities
  • Contact
MENU
  • Manufacturing & Discovery Services
    • Manufacturing & Discovery Services Overview
    • Gene Editing Design & Optimization
    • Process Development
    • Analytical Development
    • cGMP Manufacturing
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • Certifications & Compliance
    • Generative AI
  • Technologies
    • Technologies Overview
    • Gene Editing
    • Viral and Non-Viral Delivery
    • Messenger RNA (mRNA)
    • Induced Pluripotent Stem Cells (iPSCs)
  • Advanced Therapies
  • Partner With Us
  • About
    • About Overview
    • Our Journey
    • Our Team
    • Culture of Expedition
    • Careers
  • Media
    • Investors & Media Overview
    • Press Releases
    • Presentations & Publications
    • Elevated Insights
  • Careers
  • Facilities
  • Contact